Objective: To determine whether subjects with insomnia report greater reduc
tions in quality of life (QoL) than subjects without insomnia when assessed
with self-report instruments.
Methods: Questionnaires were completed by individuals recruited through med
ia advertisements and screened with a structured telephone interview. Data
obtained from 261 individuals with insomnia (INS group) were compared with
those of 101 individuals with no sleep complaint, or controls (CTL group).
Results: Subjects in the INS group obtained lower mean sum scores on the Me
dical Outcomes Study Cognitive Scale than did subjects in the CTL group (25
.34+/-0.34 vs 31.91+0.58, t=9.53, p<0.0001). The INS group also obtained lo
wer mean scores on all subscales of the SF-36 Questionnaire compared with t
hose in the CTL group (teach, p<0.0001 or lower), indicating impairments ac
ross multiple QoL domains. Psychiatric assessment revealed that subjects in
the INS group obtained significantly higher mean item scores than subjects
in the control group on the Zung Depression Scale (2.22+/-0.03 vs. 1.52+/-
0.03, p<0.0001) and the Zung Anxiety Scale (1.96+/-0.02 vs. 1.40+/-0.04, p<
0.0001). In addition, subjects in the INS group reported significantly grea
ter impairments in specific QoL domains on the QoL Inventory, and the Work
and Daily Activities Inventory. No differences were observed between subjec
ts in the INS group who were receiving treatment for insomnia versus those
who were untreated.
Conclusions: The results of this study indicate that significant QoL impair
ments are associated with insomnia.